Wedbush Upgrades Sangamo BioSciences (SGMO) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street rises on revived AI momentum as earnings season picks up
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 17
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 17
Join SI Premium – FREE
Wedbush analyst Andreas Argyrides upgraded Sangamo BioSciences (NASDAQ: SGMO) from Neutral to Outperform with a price target of $16.00 (from $4.00).
For an analyst ratings summary and ratings history on Sangamo BioSciences click here. For more ratings news on Sangamo BioSciences click here.
Shares of Sangamo BioSciences closed at $2.66 yesterday.
You May Also Be Interested In
- DA Davidson Upgrades Broadcom Limited (AVGO) to Buy, 'Looks Like AI Cycle Isn't Over Quite Yet'
- Citi upgrades MercadoLibre to Buy with $2,050 price target
- Morgan Stanley Upgrades Lockheed Martin (LMT) to Overweight
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
